Clinical Trial Update: Placebo Controlled Phase IV Study to Compare the Efficacy and Safety of a Single Dose of Oral Talcid, a Single Dose of Oral Famotidine and a Single Dose of Placebo in Patients With Acute Heartburn Episodes [Phase 4]

View source ↗

Summary

A Phase IV placebo-controlled study evaluating Talcid, a single dose of oral famotidine, and placebo in patients with acute heartburn has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heartburn

Drugs mentioned

• Famotidine (generic) (famotidine)
• Talcid (famotidine)

Snippet

Sponsor: Bayer | Conditions: Heartburn | Phase 4 | Status: COMPLETED